Cargando…

Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype

BACKGROUND: We analyzed the responses to first line treatment and clinical outcomes of metastatic breast cancer patients treated with palliative doxorubicin/cyclophosphamide (AC) according to molecular cancer subtype. METHODS: A retrospective analysis was performed for 110 metastatic breast cancer p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Seong Yoon, Ahn, Jin Seok, Uhm, Ji Eun, Lim, Do Hyoung, Ji, Sang Hoon, Jun, Hyun Jung, Kim, Kyoung Ha, Chang, Myung Hee, Park, Min Jae, Cho, Eun Yoon, La Choi, Yoon, Park, Yeon Hee, Im, Young-Hyuck
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972282/ https://www.ncbi.nlm.nih.gov/pubmed/20920367 http://dx.doi.org/10.1186/1471-2407-10-527

Ejemplares similares

Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Implications of Bone-Only Metastases in Breast Cancer: Favorable Preference with Excellent Outcomes of Hormone Receptor Positive Breast Cancer
por: Lee, Su Jin, et al.
Publicado: (2011)

A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jung, Hae Hyun, et al.
Publicado: (2023)

Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2016)

The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment
por: Kim, Ji-Yeon, et al.
Publicado: (2016)

Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency
por: Jung, Hae Hyun, et al.
Publicado: (2016)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells
por: Lee, Sol, et al.
Publicado: (2022)

The incidence and clinical features of PEGylated filgrastim-induced acute aortitis in patients with breast cancer
por: Lee, Sang Yoon, et al.
Publicado: (2020)

Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model
por: Jung, Wongeon, et al.
Publicado: (2023)

Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period
por: Choi, Misun, et al.
Publicado: (2017)

PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis
por: Seo, Youjeong, et al.
Publicado: (2018)

Mortality differences by surgical volume among patients with stomach cancer: a threshold for a favorable volume-outcome relationship
por: Choi, Hyeok, et al.
Publicado: (2017)

A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
por: Ji, Sang Hoon, et al.
Publicado: (2009)

The role of spinal adrenergic receptors on the antinociception of ginsenosides in a rat postoperative pain model
por: Kim, In Ji, et al.
Publicado: (2013)

Gene Expression Profiling of Breast Cancer Brain Metastasis
por: Lee, Ji Yun, et al.
Publicado: (2016)

Lipid Emulsion Inhibits the Late Apoptosis/Cardiotoxicity Induced by Doxorubicin in Rat Cardiomyoblasts
por: Subbarao, Raghavendra Baregundi, et al.
Publicado: (2018)

Fatal vocal cord granuloma after orthognathic surgery
por: Park, Si-Yeon, et al.
Publicado: (2018)

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
por: Kim, Se Hyun, et al.
Publicado: (2016)

Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
por: Jung, Hae Hyun, et al.
Publicado: (2021)

Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry Data
por: Kim, Eun Kyoung, et al.
Publicado: (2019)

Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability
por: Ahn, Soomin, et al.
Publicado: (2021)

The Role of Inducible Nitric Oxide Synthase Following Spinal Cord Injury in Rat
por: Kwak, Eun Kyoung, et al.
Publicado: (2005)

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2016)

Which Clinicopathologic Parameters Suggest Primary Resistance to Palbociclib in Combination With Letrozole as the First-Line Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer?
por: Kim, Ji-Yeon, et al.
Publicado: (2021)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
por: Kim, Hye Ryun, et al.
Publicado: (2016)

Predictors of favorable soft tissue profile outcomes following Class II Twin-block treatment
por: Kim, Ji-Eun, et al.
Publicado: (2018)

Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer
por: Park, Yeon Hee, et al.
Publicado: (2015)

Support Vector Regression-based Model to Analyze Prognosis of Infants with Congenital Muscular Torticollis
por: Seo, Suk-Tae, et al.
Publicado: (2010)

Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study
por: Bang, Soo-Mee, et al.
Publicado: (2021)

Additive interaction of intrathecal ginsenosides and neostigmine in the rat formalin test
por: Park, Cheon-Hee, et al.
Publicado: (2013)

Stepwise Rehabilitation of the Triple Amputee Combined With Dysfunction of the Sound Limb
por: Shin, Ji Cheol, et al.
Publicado: (2014)

Intra-tumoral Metastatic Double Primary Carcinoma: Synchronous Metastatic Tumor in Lung from Breast and Thyroid Carcinoma
por: Park, Lee Chun, et al.
Publicado: (2014)

Preservation of Cerebellar Afferent Pathway May Be Related to Good Hand Function in Patients with Stroke
por: Shin, Bo Kyung, et al.
Publicado: (2022)

Hydrangea serrata Hot Water Extract and Its Major Ingredient Hydrangenol Improve Skin Moisturization and Wrinkle Conditions via AP-1 and Akt/PI3K Pathway Upregulation
por: Yoon, Ji Hye, et al.
Publicado: (2023)

Synergism of a novel MCL-1 downregulator, acriflavine, with navitoclax (ABT-263) in triple-negative breast cancer, lung adenocarcinoma and glioblastoma multiforme
por: Lee, Anbok, et al.
Publicado: (2021)

Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy
por: Heo, Mi Hwa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9qrlb8au4plvvcjnpu5g3n6rcm